Refreshing results…
ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of ALK mutation
Download from onlinelibrary.wiley.comRepotrectinib (TPX-0005), effectively reduces growth of ALK driven neuroblastoma cells
Download from www.nature.comMissing publications? Search for publications with a matching author name.